Zhejiang Tianyu Pharmaceutical Co., Ltd. (300702.SZ) has a MoatMap StockRank of 28/100 based on Quality (49/100), Value (30/100), and Momentum (36/100) factor scores. The current signal is SELL. Zhejiang Tianyu Pharmaceutical is an API manufacturer. It operates primarily in the highly competitive generic API market rather than the high-barrier, validated biologics CDMO space, leaving it exposed to price erosion.
Zhejiang Tianyu Pharmaceutical Co., Ltd. manufactures active pharmaceutical ingredients (APIs) and intermediates, specializing in cardiovascular drugs, particularly the sartan class of antihypertensives. The company's competitive moat is established through its massive production capacity, cost-efficient chemical synthesis, and stringent compliance with global regulatory standards (FDA, EMA). It is a leading global API supplier, deeply integrated into the supply chains of multinational generic pharmaceutical companies.
| Price | $2.84 |
| Market Cap | $989M |
| P/E (TTM) | 68.43 |
| P/E (Forward) | 30.41 |
| Price/Book | 1.81 |
| Return on Equity | 2.6% |
| Return on Invested Capital | 5.1% |
| Debt/Equity | 48.31 |
| Gross Margin | 33.5% |
| Operating Margin | 10.4% |
| Revenue Growth | 6.9% |
| Dividend Yield | 0.3% |
| Free Cash Flow | $3M |
Zhejiang Tianyu Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).